Acridine

Acridine

SCHEMBL7872845

O=C(O)ON1C(=O)CCC1=O.c1ccc2nc3ccccc3cc2c1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
MAPT P10636 2/20 0.46
GLA P06280 2/20 0.46
HPGD P15428 2/20 0.46
ACHE P22303 1/20 0.46
PARL Q9H300 2/20 0.38
MGLL Q99685 1/20 0.38
MGAM O43451 2/20 0.37
KMT2A Q03164 4/20 0.37
KDM4E B2RXH2 3/20 0.37
MEN1 O00255 2/20 0.37
HTR3A P46098 1/20 0.37
POLB P06746 2/20 0.36
RECQL P46063 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
IKBKB O14920 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28811993 0.81 KDM4E (0.40) ALDH1A1MAPTGLAHPGDACHE
SCHEMBL7872853 0.79 MAPT (0.39) ALDH1A1MAPTGLAHPGDACHE
Acridine SCHEMBL9348926 0.77 ALDH1A1 (0.56) ALDH1A1MAPTGLAHPGDACHE
SCHEMBL9296399 0.76 HTR3A (0.43) ALDH1A1MAPTGLAHPGDACHE
SCHEMBL57128 0.76 PARL (0.38) GLAPARLMGLLKMT2AALOX12
SCHEMBL3143334 0.76 KDM4E (0.44) ALDH1A1MAPTGLAHPGDPARL
Diphenylether SCHEMBL1205239 0.76 ALDH1A1 (0.46) ALDH1A1PARLMGLLKMT2AALOX12
SCHEMBL2585788 0.75 KDM4E (0.54) ALDH1A1MAPTMGAMKMT2AKDM4E
SCHEMBL9551382 0.74 MGAM (0.54) MGAMKDM4ENPC1RAB9ATOP2A
Bicarbonate SCHEMBL28277654 0.74 MGLL (0.36) PARLMGLLKMT2AALOX12ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316595-B1 PNA synthesis using a base-labile amino protecting group AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-11-13 US disclosed
US-6121418-A PNA synthesis using a base-labile amino protecting group HOECHST AKTIENGESELLSCHAFT (DE) 2000-09-19 US disclosed
US-6046306-A SOLID PHASE SYNTHESIS OF PEPTIDE NUCLEIC ACIDS ALLOWING OLIGOMER TO BE CLEAVED OFF FROM THE SOLID SUPPORT UNDER THE ALKALINE CONDITIONS CONVENTIONALLY USED FOR OLIGONUCLEOTIDES HOECHST AKTIENGESELLSCHAFT (DE) 2000-04-04 US disclosed
EP-0672701-B1 PNA-synthesis using a base labile aminoprotecting group HOECHST AG (DE) 1999-07-28 EP disclosed
EP-0672700-B1 PNA-synthesis using an aminoprotecting group which is labile against weak acids HOECHST AG (DE) 1999-06-02 EP disclosed
EP-0672701-A1 PNA-synthesis using a base labile aminoprotecting group HOECHST AKTIENGESELLSCHAFT (DE) 1995-09-20 EP disclosed
EP-0672700-A1 PNA-synthesis using an aminoprotecting group which is labile against weak acids HOECHST AKTIENGESELLSCHAFT (DE) 1995-09-20 EP disclosed